RespireRx Pharmaceuticals Inc. Financial Ratios — RSPI Stock

Profitability (USD)

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Return on Common Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Assets (%)	-123.79	-288.18	76.23	-83.72	-749.96	-958.94	-1,197.59	-2,183.24	-4,861.75	-2,002.48	-1,625.15	-2,495.35	-6,596.19	-2,140.63	-1,816.46
Return on Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Return on Invested Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Gross Margin (%)	- -	- -	100	100	100	- -	100	100	- -	- -	- -	- -	- -	- -	- -
EBITDA Margin (%)	- -	- -	21.91	-69.2	-5,400.91	- -	-7,057.06	-6,020.18	- -	- -	- -	- -	- -	- -	- -
Operating Margin (%)	- -	- -	20.83	-72.63	-5,640.75	- -	-7,059.75	-6,028.37	- -	- -	- -	- -	- -	- -	- -
Incremental Operating Margin (%)	- -	- -	100.41	- -	- -	-3,281.18	- -	- -	3,718.85	- -	- -	- -	- -	- -	- -
Pretax Margin (%)	- -	- -	- -	-72.41	-15,674.6	- -	-4,390.57	-6,859.37	- -	- -	- -	- -	- -	- -	- -
Profit Margin (%)	- -	- -	15.55	-72.41	-15,674.6	- -	-4,390.57	-6,859.37	- -	- -	- -	- -	- -	- -	- -
Net Income to Common Margin (%)	- -	- -	15.55	-72.41	-15,674.6	- -	-20,705.25	-6,867.27	- -	- -	- -	- -	- -	- -	- -
Effective Tax Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Dvd Payout Ratio (%)	- -	8.97	- -	- -	- -	- -	78.79	0.12	0.01	- -	- -	- -	- -	- -	- -
Sustainable Growth Rate (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Credit (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Total Debt	- -	- -	- -	- -	- -	1	1	1	1	1	1	2	2	2	3
ST Debt	- -	- -	- -	- -	- -	1	1	1	1	1	1	2	2	2	3
LT Debt	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/EBITDA	- -	- -	- -	- -	-0.18	-0.52	-0.13	-0.16	-0.13	-0.27	-0.57	-0.94	-0.51	-0.81	-1.72
Net Debt/EBITDA	0.1	0.03	-0.45	0.75	-0.12	-0.51	-0.1	-0.15	-0.12	-0.25	-0.56	-0.93	-0.51	-0.81	-1.72
Total Debt/EBIT	- -	- -	- -	- -	-0.17	-0.52	-0.13	-0.16	-0.13	-0.27	-0.57	-0.94	-0.51	-0.81	-1.72
Net Debt/EBIT	0.1	0.03	-0.48	0.71	-0.11	-0.51	-0.1	-0.15	-0.12	-0.25	-0.56	-0.93	-0.51	-0.81	-1.72
EBITDA to Interest Expense	- -	- -	- -	-536.28	-13.25	-20.23	-37.1	-5.8	-14.44	-41.5	-15.98	-4.29	-6.08	-3.53	-2.62
EBITDA-CapEx/Interest Expense	- -	- -	- -	-536.28	-13.27	-20.23	-37.26	-5.8	-14.44	-41.5	-15.98	-4.29	-6.08	-3.53	-2.62
EBIT to Interest Expense	- -	- -	- -	-562.89	-13.83	-20.23	-37.11	-5.8	-14.45	-41.55	-15.98	-4.29	-6.08	-3.53	-2.62
Interest Expense	- -	- -	- -	- -	- -	- -	- -	1	1	- -	- -	- -	1	1	1
Common Equity/Total Assets	-2,121.51	-17,008.33	-3,320.08	-6,628.57	-64,509.57	-249,539.58	-35,492.41	-101,670.54	-67,355.42	-83,071.93	-132,369.9	-367,341.75	-200,664.06	-83,290.09	-772,276.51
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	-15.56	-14.24	-26.2	-30.16	-20.08	-26.38	-21.8	-21.95	-20.88	-20.76	-22.8
Total Debt/Capital (%)	- -	- -	- -	- -	-0.36	-0.46	-0.41	-0.59	-0.71	-0.72	-0.77	-0.99	-1	-1.21	-1.56
Total Debt/Total Assets (%)	- -	- -	- -	- -	234.19	1,149.94	144.01	591.88	471.65	589.84	1,006.43	3,605.44	1,978.74	995.52	11,890.18
Net Debt to Equity	-42.13	14.82	-43.17	-238.34	-10.47	-13.89	-18.8	-28.3	-18.4	-24.43	-21.22	-21.73	-20.87	-20.75	-22.8
Net Debt/Capital (%)	1.29	0.19	0.87	1.32	-0.24	-0.45	-0.29	-0.55	-0.65	-0.66	-0.75	-0.98	-1	-1.21	-1.56
EBITDA	-15	-8	2	-2	-3	-1	-4	-5	-8	-4	-2	-2	-3	-3	-2
EBITDA-CapEx	-15	-8	2	-2	-3	-1	-4	-5	-8	-4	-2	-2	-3	-3	-2
Operating Income (Loss)	-15	-8	2	-2	-3	-1	-4	-5	-8	-4	-2	-2	-3	-3	-2

Liquidity (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Cash Ratio	2.36	0.1	2.62	1.41	0.05	- -	0.06	0.02	0.02	0.02	0.01	- -	- -	- -	- -
Current Ratio	2.45	0.11	2.83	1.52	0.05	0.01	0.12	0.03	0.03	0.04	0.02	0.01	0.01	0.02	- -
Quick Ratio	2.36	0.1	2.62	1.41	0.05	- -	0.08	0.02	0.02	0.02	0.01	- -	- -	- -	- -
CFO/Avg Current Liab	-7.49	-3.49	0.79	-1.68	-0.86	-0.05	-0.26	-0.46	-0.3	-0.14	-0.08	-0.07	-0.07	-0.11	-0.01
Common Equity/Total Assets	-2,121.51	-17,008.33	-3,320.08	-6,628.57	-64,509.57	-249,539.58	-35,492.41	-101,670.54	-67,355.42	-83,071.93	-132,369.9	-367,341.75	-200,664.06	-83,290.09	-772,276.51
Long-Term Debt/Equity (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Capital (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Long-Term Debt/Total Assets (%)	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Total Debt/Equity (%)	- -	- -	- -	- -	-15.56	-14.24	-26.2	-30.16	-20.08	-26.38	-21.8	-21.95	-20.88	-20.76	-22.8
Total Debt/Capital (%)	- -	- -	- -	- -	-0.36	-0.46	-0.41	-0.59	-0.71	-0.72	-0.77	-0.99	-1	-1.21	-1.56
Total Debt/Total Assets (%)	- -	- -	- -	- -	234.19	1,149.94	144.01	591.88	471.65	589.84	1,006.43	3,605.44	1,978.74	995.52	11,890.18
CFO/Total Liabilities	-743.11	-310.88	115.01	-169.1	-58.36	-4.3	-34.06	-43.09	-23.2	-15.32	-7.3	-6.51	-6.3	-9.36	-1.21
CFO/CapEx	-105.46	-4,657.29	26.31	- -	-351.76	- -	-48.15	-519.06	- -	- -	- -	- -	- -	- -	- -
Altman's Z-Score	-29.42	-279.01	-34.31	-91.09	-966.87	-3,666.38	-538.27	-1,563.98	-1,090.38	-1,261.57	-1,966.26	-5,466.28	-3,052.21	-1,262.96	-11,664.99

Working Capital (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Accounts Receivable Turnover	- -	- -	- -	- -	- -	- -	2.57	3.62	- -	- -	- -	- -	- -	- -	- -
Days Sales Outstanding	- -	- -	- -	- -	- -	- -	142.05	100.79	- -	- -	- -	- -	- -	- -	- -
Inventory Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Days Inventory Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Accounts Payable Turnover Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Conversion Cycle	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventory to Cash Days	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Inventories	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Raw Materials	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Work In Process	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Finished Goods	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Other Inventory	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -

Enterprise Value (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Market Capitalization	27	6	13	7	3	4	9	7	5	3	2	- -	7	1	- -
- Cash & Cash Equivalents	1	- -	1	2	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Preferred Equity and Hybrid Capital	- -	- -	- -	- -	- -	- -	1	- -	- -	- -	- -	- -	- -	- -	- -
+ Minority/Non Controlling Interest	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
+ Total Debt	- -	- -	- -	- -	- -	1	1	1	1	1	1	2	2	2	3
Enterprise Value	23	6	10	6	3	4	10	8	6	4	3	2	9	3	3
Total Capital	-109	-120	-118	-121	-128	-129	-141	-147	-156	-161	-163	-165	-169	-172	-173
Total Debt/Capital (%)	- -	- -	- -	- -	-0.36	-0.46	-0.41	-0.59	-0.71	-0.72	-0.77	-0.99	-1	-1.21	-1.56
Total Debt / EV	- -	- -	- -	- -	0.15	0.14	0.06	0.1	0.18	0.3	0.37	0.81	0.18	0.66	0.91
EV/Sales	- -	- -	0.92	1.8	65.3	- -	162.17	94.81	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	4.21	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/EBIT	- -	- -	4.43	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
EV/Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	281.65	- -	6.49
EV/Free Cash Flow to Firm	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	281.65	- -	6.49
Diluted Market Cap	27	6	13	7	3	4	9	7	5	3	2	- -	7	1	- -
Diluted Enterprise Value	26	6	12	6	3	4	10	8	6	4	3	2	9	3	3
EV per Share	1,584.65	326.06	426.26	227.92	94.53	98.44	168.63	69.67	33.54	15.89	10.2	5.19	0.04	0.04	0.03
TTM Sales	- -	- -	10	3	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
TTM EBITDA	-15	-8	2	-2	-3	-1	-4	-5	-8	-4	-2	-2	-3	-3	-2
TTM Operating Income	-15	-8	2	-2	-3	-1	-4	-5	-8	-4	-2	-2	-3	-3	-2
TTM Cash Flow to Firm	- -	- -	- -	-2	-2	- -	-1	- -	-1	-1	- -	- -	- -	- -	- -
TTM Free Cash Flow to Firm	- -	- -	- -	-2	-2	- -	-1	- -	-1	-1	- -	- -	- -	- -	- -

Multiples (USD)

API Chat

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Price/Free Cash Flow	-2.11	-0.84	9.12	-3.72	-1.52	-20.61	-10.02	-5.53	-3.93	-3.96	-5.1	-0.8	-14.62	-1.08	-1.78
EV/EBIT	- -	- -	4.43	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Enterprise Value	23	6	10	6	3	4	10	8	6	4	3	2	9	3	3
Low Price	1,332.47	227.49	296.07	169	65	75.07	78	32.5	15	8	4	0.8	0.02	0.01	- -
EV/Sales	- -	- -	0.92	1.8	65.3	- -	162.17	94.81	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA	- -	- -	4.21	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings	- -	- -	7.78	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Price/Earnings Average	-2.5	-1.68	7.72	-3.94	-0.95	-4.77	-0.64	-2.1	-1.17	-1.3	-1.35	-1.12	-13.79	-0.88	-0.42
Price/Earnings High	-4.04	-3.79	11.08	-6.74	-1.5	-11.87	-1.36	-3.93	-2.49	-2.48	-3.75	-1.57	-90.17	-2.67	-1.01
Price/Earnings Low	-1.34	-0.42	4.12	-1.84	-0.29	-2.77	-0.36	-0.64	-0.3	-0.45	-0.52	-0.15	-1.2	-0.17	-0.12
Price/Book Value	-0.25	-0.05	-0.11	-0.06	-0.02	-0.03	-0.06	-0.05	-0.03	-0.02	-0.01	- -	-0.04	-0.01	- -
Price/Book Value Average	-0.33	-0.13	-0.11	-0.07	-0.06	-0.04	-0.06	-0.08	-0.07	-0.03	-0.02	-0.01	-0.35	-0.02	-0.01
Price/Book Value High	-0.54	-0.29	-0.15	-0.13	-0.09	-0.11	-0.12	-0.16	-0.15	-0.07	-0.06	-0.02	-2.27	-0.05	-0.01
Price/Book Value Low	-0.18	-0.03	-0.06	-0.03	-0.02	-0.03	-0.03	-0.03	-0.02	-0.01	-0.01	- -	-0.03	- -	- -
Price/Tangible Book Value	8.09	-3.74	5.32	11	-0.94	-0.89	-2.81	-2.28	-0.95	-0.63	-0.38	-0.05	-0.93	-0.1	-0.02
Price/Tangible Book Value Average	10.82	-10.04	5.28	13.57	-2.38	-1.36	-2.63	-3.98	-1.96	-1.27	-0.61	-0.32	-7.34	-0.28	-0.07
Price/Tangible Book Value High	17.48	-22.68	7.58	23.23	-3.78	-3.39	-5.6	-7.46	-4.17	-2.43	-1.69	-0.44	-47.97	-0.84	-0.18
Price/Tangible Book Value Low	5.78	-2.52	2.82	6.36	-0.72	-0.79	-1.49	-1.22	-0.51	-0.44	-0.23	-0.04	-0.64	-0.05	-0.02
Price/Sales	- -	- -	1.21	2.31	58.37	- -	140.96	82.27	- -	- -	- -	- -	- -	- -	- -
Price/Sales Average	- -	- -	1.2	2.85	148.74	- -	132.13	144.02	- -	- -	- -	- -	- -	- -	- -
Price/Sales High	- -	- -	1.72	4.88	235.71	- -	281.29	269.81	- -	- -	- -	- -	- -	- -	- -
Price/Sales Low	- -	- -	0.64	1.34	44.9	- -	75.01	44.23	- -	- -	- -	- -	- -	- -	- -
Price/Cash Flow	-2.09	-0.84	9.47	-3.72	-1.51	-20.61	-9.81	-5.52	-3.93	-3.96	-5.1	-0.8	-14.62	-1.08	-1.78
Price/Cash Flow Average	-2.8	-2.24	9.39	-4.59	-3.86	-31.42	-9.2	-9.66	-8.15	-7.99	-8.16	-4.84	-115.61	-2.9	-6.15
Price/Cash Flow High	-4.52	-5.06	13.48	-7.85	-6.12	-78.16	-19.58	-18.09	-17.33	-15.27	-22.74	-6.81	-756.01	-8.78	-14.7
Price/Cash Flow Low	-1.49	-0.56	5.01	-2.15	-1.16	-18.24	-5.22	-2.97	-2.1	-2.78	-3.14	-0.64	-10.08	-0.55	-1.7
Price/Free Cash Flow Average	-2.82	-2.24	9.05	-4.59	-3.87	-31.42	-9.39	-9.68	-8.15	-7.99	-8.16	-4.84	-115.61	-2.9	-6.15
Price/Free Cash Flow High	-4.56	-5.06	12.99	-7.85	-6.13	-78.16	-20	-18.13	-17.33	-15.27	-22.74	-6.81	-756.01	-8.78	-14.7
Price/Free Cash Flow Low	-1.51	-0.56	4.83	-2.15	-1.17	-18.24	-5.33	-2.97	-2.1	-2.78	-3.14	-0.64	-10.08	-0.55	-1.7
EV/Sales Average	- -	- -	1.1	2.34	155.68	- -	153.34	156.56	- -	- -	- -	- -	- -	- -	- -
EV/Sales High	- -	- -	1.63	4.37	242.64	- -	302.51	282.35	- -	- -	- -	- -	- -	- -	- -
EV/Sales Low	- -	- -	0.54	0.83	51.83	- -	96.23	56.78	- -	- -	- -	- -	- -	- -	- -
EV/EBITDA Average	-2.36	-1.88	5.04	-3.38	-2.88	-5.56	-2.17	-2.6	-1.4	-1.57	-2.17	-2.3	-18.4	-1.9	-2.29
EV/EBITDA High	-3.87	-4.29	7.42	-6.31	-4.49	-13.04	-4.29	-4.69	-2.84	-2.76	-5.03	-2.86	-117.5	-4.1	-3.07
EV/EBITDA Low	-1.22	-0.45	2.48	-1.19	-0.96	-3.45	-1.36	-0.94	-0.45	-0.71	-1.18	-1.12	-2.07	-1.03	-1.88
EV/EBIT Average	-2.33	-1.84	5.3	-3.22	-2.76	-5.56	-2.17	-2.6	-1.4	-1.57	-2.17	-2.3	-18.4	-1.9	-2.29
EV/EBIT High	-3.83	-4.19	7.81	-6.02	-4.3	-13.04	-4.28	-4.68	-2.84	-2.76	-5.03	-2.86	-117.5	-4.1	-3.07
EV/EBIT Low	-1.2	-0.44	2.61	-1.14	-0.92	-3.45	-1.36	-0.94	-0.45	-0.71	-1.18	-1.12	-2.07	-1.03	-1.88
Last Price	1,866.1	337.99	558.99	292.49	84.5	84.82	146.57	60.45	28	11.4	6.5	1	0.03	0.01	- -
High Price	4,029.9	2,047.45	796.23	617.48	341.24	321.74	292.49	198.25	123.5	44	29	8.5	1.5	0.1	0.02
Enterprise Value Average	35	15	12	7	8	6	9	14	12	7	5	4	61	5	4
Enterprise Value High	58	35	17	14	12	15	19	25	24	12	11	5	390	10	5
Enterprise Value Low	18	4	6	3	3	4	6	5	4	3	3	2	7	3	3

	2008 Y	2009 Y	2010 Y	2011 Y	2012 Y	2013 Y	2014 Y	2015 Y	2016 Y	2017 Y	2018 Y	2019 Y	2020 Y	2021 Y	2022 Y
Shares Outstanding	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	71	98	126
Diluted Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	259	88	111
Basic Weighted Avg Shares	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	259	88	111
Revenue per Share	- -	- -	462	126.55	1.45	- -	1.04	0.73	- -	- -	- -	- -	- -	- -	- -
EBITDA per Share	-1,016.19	-474.7	101.21	-87.57	-78.19	-25.72	-73.38	-44.23	-45.41	-17.54	-6.49	-4.44	-0.01	-0.03	-0.01
Operating Income per Share	-1,027.46	-485.6	96.25	-91.92	-81.66	-25.72	-73.41	-44.29	-45.45	-17.56	-6.49	-4.44	-0.01	-0.03	-0.01
Basic EPS, GAAP	-997.19	-540.26	71.84	-91.63	-226.92	-27.11	-215.3	-50.46	-49.52	-17.75	-7.73	-5.41	-0.02	-0.04	-0.02
Basic EPS from Cont Ops	-997.19	-491.81	71.84	-91.63	-226.92	-27.11	-45.65	-50.4	-49.51	-17.75	-7.73	-5.41	-0.02	-0.04	-0.02
Diluted EPS, GAAP	-997.19	-540.26	71.83	-91.63	-226.92	-27.11	-215.3	-50.46	-49.52	-17.75	-7.73	-5.41	-0.02	-0.04	-0.02
Diluted EPS from Cont Ops	-997.19	-491.81	71.83	-91.63	-226.92	-27.11	-45.65	-50.4	-49.51	-17.75	-7.73	-5.41	-0.02	-0.04	-0.02
Dividend per Share	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -	- -
Cash Flow per Share	-891.31	-404.57	59.05	-78.65	-55.8	-4.12	-14.94	-10.96	-7.13	-2.88	-1.28	-1.25	- -	-0.01	- -
Free Cash Flow per Basic Share	-899.76	-404.66	56.81	-78.65	-55.96	-4.12	-15.25	-10.98	-7.13	-2.88	-1.28	-1.25	- -	-0.01	- -
Cash & Equivalents per Share	282.94	13.19	133.68	65.45	4.56	0.32	2.74	0.45	0.49	0.35	0.1	0.04	- -	- -	- -
Book Value per Share	-7,467.87	-6,995.72	-5,224.32	-4,903.44	-3,841.81	-2,919.58	-2,395.69	-1,253.49	-844.99	-669.07	-490.56	-426.02	-0.66	-1.97	-1.58
Tangible Book Value per Share	230.58	-90.27	105.05	26.58	-90.31	-94.99	-52.18	-26.57	-29.59	-18.1	-17.17	-19.1	-0.03	-0.11	-0.11

RespireRx Pharmaceuticals Inc.

Profitability (USD)

Credit (USD)

Liquidity (USD)

Working Capital (USD)

Enterprise Value (USD)

Multiples (USD)

Per Share Data Items (USD)